Acceder Registro /

Gloria Soler Sánchez

Buscador

Ferrer-Marín F, Bellosillo B, Martínez-Avilés L, Soler G, Carbonell P, Luengo-Gil G, Caparrós E, Torregrosa JM, Besses C, Vicente V. Leukemic transformation driven by an ASXL1 mutation after a JAK2V617F-positive primary myelofibrosis: clonal evolution and hierarchy revealed by next-generation sequencing. J Hematol Oncol. 2013 Sep 8;6:68. doi: 10.1186/1756-8722-6-68. PubMed PMID: 24011025; PubMed Central PMCID: PMC3847205.
AÑO: 2013; IF: 11.059
Soler G, Bernal-Vicente A, Antón AI, Torregrosa JM, Caparrós-Pérez E, Sánchez-Serrano I, Martínez-Pérez A, Sánchez-Vega B, Vicente V, Ferrer-Marin F. The JAK2 46/1 haplotype does not predispose to CALR-mutated myeloproliferative neoplasms. Ann Hematol. 2015 May;94(5):789-94. doi: 10.1007/s00277-014-2266-y. PubMed PMID: 25482455.
AÑO: 2015; IF: 3.022
Autores:
Torregrosa JM, Soler G, Cancio S, Ferrer-Marin F. [Concurrent lymphoid and Philadelphia chromosome-negative myeloproliferative neoplasms]. Med Clin (Barc). 2015 Oct 5;145(7):318-9. doi: 10.1016/j.medcli.2014.11.012. Spanish. PubMed PMID: 25618739.
AÑO: 2015; IF: 1.267
Autores:
Jara-Palomares L, Alfonso M, Maestre A, Jimenez D, Garcia-Bragado F, Font C, Reyes RL, Blasco LH, Vidal G, Otero R, Monreal M; RIETE investigators. Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years. Sci Rep. 2019 Dec 27;9(1):20064. doi: 10.1038/s41598-019-55213-8. PubMed PMID: 31882805; PubMed Central PMCID: PMC6934558.
AÑO: 2019; IF: 3.998
Autores:
Golemi I, Cote L, Iftikhar O, Brenner B, Tafur A, Bikdeli B, Fernández-Capitán C, Pedrajas JM, Otero R, Quintavalla R, Monreal M; Registro Informatizado de Enfermedad Tromboembólica Investigators. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry. J Vasc Surg Venous Lymphat Disord. 2020 May;8(3):353-359.e1. doi: 10.1016/j.jvsv.2019.03.011. Epub 2019 Nov 26. PubMed PMID: 31784355.
AÑO: 2020; IF: 2.859
Autores:

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R